Protein Kinase C at the Crossroad of Mutations, Cancer, Targeted Therapy and Immune Response

Abstract excerpt

The frequent PKC dysregulations observed in many tumors have made these enzymes natural targets for anticancer applications. Nevertheless, this considerable interest in the development of PKC modulators has not led to the expected therapeutic benefits, likely due to the complex biological activities regulated by PKC isoenzymes, often playing ambiguous and protective functions, further driven by the occurrence of...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Chronic Lymphocytic Leukemia Research
• Share to Melanoma and MAPK Pathways
• Share to Protein Kinase Regulation and GTPase Signaling